These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 5677962)
41. PLASMA VOLUME EXPANSION BY RAPID INFUSION OF A LOW MOLECULAR WEIGHT DEXTRAN. DAVIES JW; RICKETTS CR; WILLIAMS BN Br J Pharmacol Chemother; 1963 Oct; 21(2):220-5. PubMed ID: 14081651 [TBL] [Abstract][Full Text] [Related]
42. [PURPOSEFUL SHOCK CONTROL]. REISSIGL H Med Welt; 1964 Feb; 5():232-40. PubMed ID: 14137764 [No Abstract] [Full Text] [Related]
43. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia. Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686 [TBL] [Abstract][Full Text] [Related]
44. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II. Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122 [TBL] [Abstract][Full Text] [Related]
46. The behaviour of clinical standard values after infusions of plasma substitutes. Eichler J; Stephan G Bibl Haematol; 1969; 33():536-42. PubMed ID: 5384020 [No Abstract] [Full Text] [Related]
47. Treatment of essential hyperlipidaemia. Fredrickson DS; Levy RI Lancet; 1970 Jan; 1(7639):191-2. PubMed ID: 4189261 [No Abstract] [Full Text] [Related]
48. [A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)]. Mordasini R; Twelsick F; Oster P; Schellenberg B; Raetzer H; Heuck CC; Schlierf G Monatsschr Kinderheilkd (1902); 1978 Jul; 126(7):436-40. PubMed ID: 672910 [TBL] [Abstract][Full Text] [Related]
50. [The importance of determining the type of hyperlipidemia for lipotropic therapy of atherosclerosis]. Bavina MV; Perova NV; Lobova NM; Koropova GI Kardiologiia; 1973 Mar; 13(3):27-33. PubMed ID: 4717180 [No Abstract] [Full Text] [Related]
51. [Blood substitution by plasma expanders and the reactions in the blood coagulation system]. Pfeifer G Geburtshilfe Frauenheilkd; 1966 May; 26(5):720-4. PubMed ID: 5295914 [No Abstract] [Full Text] [Related]
52. [Resins in the treatment of hypercholesterolemia]. Jacotot B Med Chir Dig; 1978; 7(8):697-8. PubMed ID: 745469 [No Abstract] [Full Text] [Related]
54. [Experimental and clinical study of Vasosan P, a new form of pectin-enriched cholestyramine]. Ryzhenkov VE; Chistiakova AM; Triufanov VF; Vasil'eva LE; Frolova IuV; Solov'eva MA; Remezova OV; Lozovskiĭ VT; Khanefel'd M; Leonkhardt V Kardiologiia; 1990 Aug; 30(8):77-9. PubMed ID: 2255152 [TBL] [Abstract][Full Text] [Related]
55. [The use of hemagel in hospital practice. Review and clinical report]. Jacobellis P; Vitelli M Minerva Chir; 1966 Jan; 21(1):31-6. PubMed ID: 5910989 [No Abstract] [Full Text] [Related]
56. Treatment of experimental haemorrhagic shock in dogs. Hollmén A; Karvonen S; Saukkonen J; Valanne J Ann Chir Gynaecol Fenn; 1970; 59(3):119-26. PubMed ID: 5507359 [No Abstract] [Full Text] [Related]
57. [Clinical study of hydroxyethyl starch (HES)]. Kobayashi K; Takagi Y; Takafuji Y; Sugahara Y Masui; 1971 Aug; 20(8):742-8. PubMed ID: 5166090 [No Abstract] [Full Text] [Related]
58. The clinical status of dextran, PVP and gelatin products. PULASKI EJ Int Rec Med Gen Pract Clin; 1952 Aug; 165(8):172-9. PubMed ID: 13010904 [No Abstract] [Full Text] [Related]
59. Treatment of hyperlipidemia. Levy RI; Morganroth J; Rifkind BM N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888 [No Abstract] [Full Text] [Related]
60. Bile acid metabolism in hyperlipoproteinaemia. Hellström K; Einarsson K Clin Gastroenterol; 1977 Jan; 6(1):103-28. PubMed ID: 196796 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]